KIDS / OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

WARSAW, Ind., Oct. 17, 2023 (GLOBE NEWSWIRE) --  OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused more_horizontal

OrthoPediatrics (KIDS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not h more_horizontal

OrthoPediatrics Corp. (NASDAQ:KIDS ) Q2 2023 Earnings Conference Call August 1, 2023 8:00 AM ET Company Participants Trip Taylor - Investor Relations, more_horizontal

While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended June 2023, it could more_horizontal

OrthoPediatrics (KIDS) came out with a quarterly loss of $0.19 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.17 per more_horizontal

WARSAW, Ind., July 18, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused e more_horizontal

The GIRO Growth Modulation System by OrthoPediatrics (KIDS) introduces a tether device designed specifically for pediatric patients. more_horizontal

OrthoPediatrics Corp. (NASDAQ:KIDS ) Q1 2023 Results Conference Call May 2, 2023 8:00 AM ET Company Participants Trip Taylor - IR, Gilmartin Group Dav more_horizontal